Wei, T.; Li, Z.; Lin, C.; Yang, Y.; Tie, C.; Cai, X.; Lv, F.; Yang, W.; Ji, L.
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis. Pharmaceuticals 2025, 18, 1095.
https://doi.org/10.3390/ph18081095
AMA Style
Wei T, Li Z, Lin C, Yang Y, Tie C, Cai X, Lv F, Yang W, Ji L.
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis. Pharmaceuticals. 2025; 18(8):1095.
https://doi.org/10.3390/ph18081095
Chicago/Turabian Style
Wei, Tingyang, Zonglin Li, Chu Lin, Yuteng Yang, Changjie Tie, Xiaoling Cai, Fang Lv, Wenjia Yang, and Linong Ji.
2025. "PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis" Pharmaceuticals 18, no. 8: 1095.
https://doi.org/10.3390/ph18081095
APA Style
Wei, T., Li, Z., Lin, C., Yang, Y., Tie, C., Cai, X., Lv, F., Yang, W., & Ji, L.
(2025). PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis. Pharmaceuticals, 18(8), 1095.
https://doi.org/10.3390/ph18081095